D. E. Shaw & Co »

Prime Medicine shares owned by D. E. Shaw & Co

Quarter-by-quarter ownership of Prime Medicine (PRME) shares owned by D. E. Shaw & Co from 13F filings

Historical chart of D. E. Shaw & Co investment in Prime Medicine

Tip: Access up to 7 years of quarterly data

All positions including Prime Medicine held by D. E. Shaw & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Prime Medicine by D. E. Shaw & Co

Quarter filed Position value Share count Share price at filing
2024-09-30 $540k 140k 3.87
2024-06-30 $234k 45k 5.14
2024-03-31 $187k 27k 7.00

More positions owned by D. E. Shaw & Co

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Meta Platforms Cl A Put Option (META)
Amazon (AMZN)
Tesla Motors Put Option (TSLA)
Netflix Put Option (NFLX)
Booking Holdings Call Option (BKNG)
Advanced Micro Devices Put Option (AMD)
Broadcom Put Option (AVGO)
Eli Lilly & Co. Call Option (LLY)
Alphabet Cap Stk Cl A (GOOGL)
Bank of America Corporation (BAC)
Palantir Technologies Cl A (PLTR)
Citigroup Com New Put Option (C)

View all positions for D. E. Shaw & Co

Top funds holding Prime Medicine

Alphabet
Vanguard Group
ARK Investment Management
BlackRock
BlackRock
T. Rowe Price Investment Management
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Redmile Group
MWG Management
T. Rowe Price Associates
Geode Capital Management
State Street Corporation
Vestal Point Capital
Baker Bros. Advisors

View all funds holding Prime Medicine